About Oncology Nursing Drug Handbook
Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.
Key Features
- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)
Similar Apps
Saunders Comp Review NCLEX RN
Often called the ‘the best NCLEX® exam review book ever,’ Saunders Comprehensive...
CURRENT Med Diag & Treatment
"Try before you buy" - Download the FREE App, which includes sample...
Pocket Anatomy and Physiology
Pocket Anatomy and Physiology provides mobile healthcare practitioners with the latest in...
Saunders Nursing Drug Handbook
The go-to guide for students and nurses alike to promote better patient...
Saunders Comp Review NCLEX PN
Skyscape's App is based on the print edition of the Saunders Comprehensive...
NCLEX RN Q&A Tutoring Saunders
Practice makes perfect with Saunders Q&A Review for the NCLEX-RN® Examination, 7th...
Frequently Asked Questions (FAQ)
What is the focus of the Oncology Nursing Drug Handbook?
What does the 2020-2021 edition of the Oncology Nursing Drug Handbook include?
What information does the handbook provide on symptom management and patient education?
Which new drugs are included in the 2020-2021 edition of the handbook?
What updates have been made to the handbook regarding recently FDA approved drugs?
